Restricted accessResearch articleFirst published online 2023-09
Premature Menopause and All-Cause Mortality and Life Span Among Women Older Than 40 Years in the NHANES I Epidemiologic Follow-Up Study: Propensity Score Matching Analysis
Findings from studies of the long-term effect of premature menopause on risks of all-cause mortality in women are equivocal. We used the approach of propensity score matching to examine the causal association of premature menopause with all-cause mortality and life span among women older than 40 years.
Methods:
The data were from the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. We calculated the propensity score of premature menopause using a logistic regression model, then matched premature menopause with nonpremature menopause according to the score and the ratio of 1:1. We estimated mortality hazard ratios (HRs) and 95% confidence intervals (CIs) using Cox proportional hazard models. We also analyzed and plotted the relationship between age at menopause and reproductive life span with all-cause mortality and life span.
Results:
The mean age of 1,210 women was 55.4 ± 10.8 years at baseline. The unadjusted and adjusted HRs of all-cause mortality for women with premature menopause were 1.46 (95% CI: 1.08–1.96) and 1.53 (95% CI: 1.13–2.08), respectively, compared to nonpremature menopause. Nonlinear associations were found between age at menopause, reproductive life span, all-cause mortality, and life span. Menopausal age <37.5 years of age or reproductive life span <24 years increased the risk of all-cause mortality. Women with menopausal age <39 years of age or reproductive life span <24 years had a lower mean life span than the overall average of 76 years.
Conclusions:
Premature menopause significantly increased all-cause mortality risk and shortened life span in women. As women's age at menopause or reproductive life span increases, their overall life span also tends to increase.
Get full access to this article
View all access options for this article.
References
1.
GoldEB, CrawfordSL, AvisNE, et al.Factors related to age at natural menopause: Longitudinal analyses from SWAN. Am J Epidemiol, 2013; 178(1):70–83; doi: 10.1093/aje/kws421
2.
KingsbergSA, LarkinLC, LiuJH. Clinical effects of early or surgical menopause. Obstet Gynaecol, 2020; 135(4):853–868; doi: 10.1097/aog.0000000000003729
3.
ZhuD, ChungHF, DobsonAJ, et al.Age at natural menopause and risk of incident cardiovascular disease: A pooled analysis of individual patient data. Lancet Public Health, 2019; 4(11):e553–e564; doi: 10.1016/s2468-2667(19)30155-0
4.
HuanL, DengX, HeM, et al.Meta-analysis: Early age at natural menopause and risk for all-cause and cardiovascular mortality. Biomed Res Int, 2021; 2021:1–14; doi: 10.1155/2021/6636856
5.
HonigbergMC, ZekavatSM, AragamK, et al.Association of premature natural and surgical menopause with incident cardiovascular disease. JAMA, 2019; 322(24):2411–2421; doi: 10.1001/jama.2019.19191
6.
AmagaiY, IshikawaS, GotohT, et al.Age at menopause and mortality in Japan: The Jichi Medical School cohort study. J Epidemiol, 2006; 16(4):161–166; doi: 10.2188/jea.16.161
7.
MondulAM, RodriguezC, JacobsEJ, et al.Age at natural menopause and cause-specific mortality. Am J Epidemiol, 2005; 162(11):1089–1097; doi: 10.1093/aje/kwi324
8.
ShadyabAH, MaceraCA, ShafferRA, et al.Ages at menarche and menopause and reproductive lifespan as predictors of exceptional longevity in women: The Women's Health Initiative. Menopause, 2017; 24(1):35–44; doi: 10.1097/GME.0000000000000710
9.
WuX, CaiH, KallianpurA, et al.Age at menarche and natural menopause and number of reproductive years in association with mortality: Results from a median follow-up of 11.2 years among 31,955 naturally menopausal Chinese women. PLoS One, 2014; 9(8):e103673; doi: 10.1371/journal.pone.0103673
10.
CooperGS, SandlerDP. Age at natural menopause and mortality. Ann Epidemiol, 1998; 8(4):229–235; doi: 10.1016/s1047-2797(97)00207-x
11.
JaspersL, KavousiM, ErlerNS, et al.Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: The Rotterdam Study. Fertil Steril, 2017; 107(2):448–456; doi: 10.1016/j.fertnstert.2016.11.006
12.
TomSE, CooperR, WallaceRB, et al.Type and timing of menopause and later life mortality among women in the Iowa Established Populations for the Epidemiological Study of the Elderly (EPESE) cohort. J Womens Health, 2012; 21(1):10–16; doi: 10.1089/jwh.2011.2745
13.
LiS, RosenbergL, WiseLA, et al.Age at natural menopause in relation to all-cause and cause-specific mortality in a follow-up study of US black women. Maturitas, 2013; 75(3):246–252; doi: 10.1016/j.maturitas.2013.04.003
14.
MukaT, Oliver-WilliamsC, KunutsorS, et al.Association of age at onset of menopause and time since onset of menopause with cardiovascular outcomes, intermediate vascular traits, and all-cause mortality: A systematic review and meta-analysis. JAMA Cardio, 2016; 1(7):767–776; doi: 10.1001/jamacardio.2016.2415
15.
ShenTY, StrongC, YuT. Age at menopause and mortality in Taiwan: A cohort analysis. Maturitas, 2020; 136:42–48; doi: 10.1016/j.maturitas.2020.04.008
16.
OssewaardeME, BotsML, VerbeekALM, et al.Age at menopause, cause-specific mortality and total life expectancy. Epidemiology, 2005; 16(4):556–562; doi: 10.1097/01.ede.0000165392.35273.d4
17.
NilssonPM, NilssonE, SvanbergL, et al.Longevity after early surgical menopause—The long-term effect of a permanent cessation of reproductive function and female sex hormone loss. Eur J Obstet Gynecol Reprod Biol, 2003; 110(1):63–65; doi: 10.1016/s0301-2115(03)00085-x
18.
KaneLT, FangT, GalettaMS, et al.Propensity score matching: A statistical method. Clin Spine Surg, 2020; 33(3):120–122; doi: 10.1097/bsd.0000000000000932
19.
CoxCS, FeldmanJJ, GoldenCD, et al.Plan and Operation of the NHANES I Epidemiologic Followup Study, 1992. Centers for Disease Control and Prevention: Atlanta, Georgia;, 1997; PMID: 9564279.
20.
EleazuIC, Jones-O'ConnorM, HonigbergMC. The impact of premature menopause on future risk of cardiovascular disease. Curr Treat Options Cardiovasc Med, 2020; 22(12):1–11; doi: 10.1007/s11936-020-00854-6
21.
XuZ, ChungHF, DobsonAJ, et al.Menopause, hysterectomy, menopausal hormone therapy and cause-specific mortality: Cohort study of UK Biobank participants. Hum Reprod, 2022; 37(9):2175–2185; doi: 10.1093/humrep/deac137
22.
ZhangX, XiaJ, Del GobboLC, et al.Serum magnesium concentrations and all-cause, cardiovascular, and cancer mortality among US adults: Results from the NHANES I Epidemiologic Follow-up Study. Clin Nutr, 2018; 37(5):1541–1549; doi: 10.1016/j.clnu.2017.08.021
23.
CrimminsEM. Lifespan and healthspan: Past, present, and promise. Gerontologist, 2015; 55(6):901–911; doi: 10.1093/geront/gnv130
24.
WangY, CaiH, LiC, et al.Optimal caliper width for propensity score matching of three treatment groups: A Monte Carlo study. PLoS One, 2013; 8(12):e81045; doi: 10.1371/journal.pone.0081045
25.
AustinPC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat, 2011; 10(2):150–161; doi: 10.1002/pst.433
26.
AustinPC. A comparison of 12 algorithms for matching on the propensity score. Stat Med, 2014; 33(6):1057–1069; doi: 10.1002/sim.6004
27.
ZhaoXR, TangY, WuHF, et al.Influence of age as a continuous variable on the prognosis of patients with pT1-2N1 breast cancer. Breast, 2022; 66:136–144; doi: 10.1016/j.breast.2022.08.005
28.
HelwigNE, HelwigMNE. Package ‘npreg’. 2022. Available from: https://cloud.r-project.org/web/packages/npreg/npreg.pdf
29.
LeeTCM. Improved smoothing spline regression by combining estimates of different smoothness. Stat Probab Lett, 2004; 67(2):133–140; doi: 10.1016/j.spl.2004.01.003
30.
PerperoglouA, SauerbreiW, AbrahamowiczM, et al.A review of spline function procedures in R. BMC Med Res Methodol, 2019; 19(1):1–16; doi: 10.1186/s12874-019-0666-3
31.
AsllanajE, BanoA, GlisicM, et al.Age at natural menopause and life expectancy with and without type 2 diabetes. Menopause, 2019; 26(4):387–394; doi: 10.1097/gme.0000000000001246
32.
LayAAR, do NascimentoCF, de Oliveira DuarteYA, et al.Age at natural menopause and mortality: A survival analysis of elderly residents of São Paulo, Brazil. Maturitas, 2018; 117:29–33; doi: 10.1016/j.maturitas.2018.08.012
33.
JacobsenBK, HeuchI, KvåleG. Age at natural menopause and all-cause mortality: A 37-year follow-up of 19,731 Norwegian women. Am J Epidemiol, 2003; 157(10):923–929; doi: 10.1093/aje/kwg066
34.
MishraSR, ChungHF, WallerM, et al.Duration of estrogen exposure during reproductive years, age at menarche and age at Menopause, and risk of cardiovascular disease events, all-cause and cardiovascular mortality: A systematic review and meta-analysis. BJOG, 2021; 128(5):809–821; doi: 10.1111/1471-0528.16524
35.
MerrittMA, RiboliE, MurphyN, et al.Reproductive factors and risk of mortality in the European Prospective Investigation into Cancer and Nutrition; a cohort study. BMC Med, 2015; 13:1–15; doi: 10.1186/s12916-015-0484-3
36.
QianD, WangZ, ChengY, et al.Early menopause may associate with a higher risk of CKD and all-cause mortality in postmenopausal women: An analysis of NHANES, 1999–2014. Front Med, 2022; 9:823–835; doi: 10.3389/fmed.2022.823835
37.
ShusterLT, RhodesDJ, GostoutBS, et al.Premature menopause or early menopause: Long-term health consequences. Maturitas, 2010; 65(2):161–166; doi: 10.1016/j.maturitas.2009.08.003
38.
MansoorH, Elgendy IY, SegalR, et al.Duration of reproductive years and the risk of cardiovascular and cerebrovascular events in older women: Insights from the National Health and Nutrition Examination Survey. J Womens Health, 2017; 26(10):1047–1052; doi: 10.1089/jwh.2016.6013
39.
AtsmaF, BartelinkMLEL, GrobbeeDE, et al.Postmenopausal status and early menopause as independent risk factors for cardiovascular disease: A meta-analysis. Menopause, 2006; 13(2):265–279; doi: 10.1097/01.gme.0000218683.97338.ea
40.
De KleijnMJJ, Van der SchouwYT, VerbeekALM, et al.Endogenous estrogen exposure and cardiovascular mortality risk in postmenopausal women. Am J Epidemiol, 2002; 155(4):339–345; doi: 10.1093/aje/155.4.339
41.
ArosioB, CorbiG, DavinelliS, et al.Sex differences in cardiovascular diseases: A matter of estrogens, ceramides, and sphingosine 1-phosphate. Int J Mol Sci, 2022; 23(7):4009–4028; doi: 10.3390/ijms23074009
42.
LeeJS, YaffeK, LuiLY, et al.Prospective study of endogenous circulating estradiol and risk of stroke in older women. Arch Neurol, 2010; 67(2):195–201; doi: 10.1001/archneurol.2009.322
43.
StolkL, PerryJRB, ChasmanDI, et al.Meta-analyses identify 13 loci associated with age at menopause and highlight DNA repair and immune pathways. Nat Genet, 2012; 44(3):260–268; doi: 10.1038/ng.1051
44.
NebelA, FlachsbartF, TillA, et al.A functional EXO1 promoter variant is associated with prolonged life expectancy in centenarians. Mech Ageing Dev, 2009; 130(10):691–699; doi: 10.1016/j.mad.2009.08.004
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
